Report cover image

Global GERD Market 2023-2027

Publisher TechNavio
Published Dec 29, 2022
Length 166 Pages
SKU # INF17637522

Description

Global GERD Market 2023-2027

Technavio has been monitoring the GERD market and is forecast to grow by $908.49 mn during 2022-2027, accelerating at a CAGR of 3.4% during the forecast period. Our report on the GERD market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by the rising geriatric population, poor lifestyle patterns, and overuse of medicines and dietary supplements.

Technavio's GERD market is segmented as below:

By Route of Administration
  • Oral
  • Parenteral
By Type
  • Antacid
  • PPI
  • H2 receptor antagonist drugs
  • Pro-Kinetic drugs
By Geography
  • North America
  • Europe
  • Asia
  • Rest of World (ROW)
This study identifies the rising prevalence of obesity as one of the prime reasons driving the GERD market growth during the next few years. Also, the growing e-commerce market and increasing awareness of GERD will lead to sizable demand in the market.

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters. Our report on the GERD market covers the following areas:
  • GERD market sizing
  • GERD market forecast
  • GERD market industry analysis
Technavio's robust vendor analysis is designed to help clients improve their market position. In line with this, this report provides a detailed analysis of several leading GERD market vendors that include Bayer AG, Alkem Laboratories Ltd., Apotex Inc., AstraZeneca Plc, Aurobindo Pharma Ltd., Cipla Ltd., Dr Reddys Laboratories Ltd., Eisai Co. Ltd., Fresenius SE and Co. KGaA, GlaxoSmithKline Plc, iNova Pharmaceuticals, Johnson and Johnson, Lupin Ltd., Perrigo Co. Plc, Pfizer Inc., SRS Life Sciences Pte. Ltd., Sun Pharmaceutical Industries Ltd., Takeda Pharmaceutical Co. Ltd., The Procter and Gamble Co., and Abbott Laboratories. Also, the GERD market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

Technavio presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. Technavio's market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.

Table of Contents

166 Pages
    • Market overview
    • Market ecosystem
    • Market definition
    • Market segment analysis
    • Market size 2022
    • Market outlook: Forecast for 2022-2027
    • Global GERD market 2017 - 2021
    • Route of administration segment analysis 2017 - 2021
    • Drug type segment analysis 2017 - 2021
    • Geography segment analysis 2017 - 2021
    • Country segment analysis 2017 - 2021
    • Five forces summary
    • Bargaining power of buyers
    • Bargaining power of suppliers
    • Threat of new entrants
    • Threat of substitutes
    • Threat of rivalry
    • Market condition
    • Market segments
    • Comparison by Route of Administration
    • Oral - Market size and forecast 2022-2027
    • Parenteral - Market size and forecast 2022-2027
    • Market opportunity by Route of Administration
    • Market segments
    • Comparison by Type
    • Antacid - Market size and forecast 2022-2027
    • PPI - Market size and forecast 2022-2027
    • H2 receptor antagonist drugs - Market size and forecast 2022-2027
    • Pro-Kinetic drugs - Market size and forecast 2022-2027
    • Market opportunity by Type
    • Customer landscape overview
    • Geographic segmentation
    • Geographic comparison
    • North America - Market size and forecast 2022-2027
    • Europe - Market size and forecast 2022-2027
    • Asia - Market size and forecast 2022-2027
    • Rest of World (ROW) - Market size and forecast 2022-2027
    • US - Market size and forecast 2022-2027
    • Germany - Market size and forecast 2022-2027
    • UK - Market size and forecast 2022-2027
    • China - Market size and forecast 2022-2027
    • Canada - Market size and forecast 2022-2027
    • Market opportunity by geography
    • Market drivers
    • Market challenges
    • Impact of drivers and challenges
    • Market trends
    • Overview
    • Vendor landscape
    • Landscape disruption
    • Industry risks
    • Vendors covered
    • Market positioning of vendors
    • Abbott Laboratories
    • Alkem Laboratories Ltd.
    • Apotex Inc.
    • AstraZeneca Plc
    • Aurobindo Pharma Ltd.
    • Bayer AG
    • Cipla Ltd.
    • Dr Reddys Laboratories Ltd.
    • Eisai Co. Ltd.
    • Fresenius SE and Co. KGaA
    • GlaxoSmithKline Plc
    • iNova Pharmaceuticals
    • Johnson and Johnson
    • Lupin Ltd.
    • Perrigo Co. Plc
    • Scope of the report
    • Inclusions and exclusions checklist
    • Currency conversion rates for US$
    • Research methodology
    • List of abbreviations

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us